Phlexglobal, a technology and services provider for the life sciences industry, announced the general availability of the industry’s first and only complete TMF management offering from a single expert provider. The company’s new PhlexTMF+ provides a one-stop, full-service solution that encompasses all the software and services required for effective TMF management and ongoing inspection-readiness. Organizations can be confident that their Trial Master File is being managed by experts every step of the way, from planning and document processing and study closeout.
With PhlexTMF+, life sciences organizations now have ready access to the latest advances in eTMF SaaS software, the world’s leading TMF experts, and best practices-based processes proven to optimize TMF quality, completeness, and timeliness – from a single provider and in one seamless offering. Companies gain ongoing TMF compliance, as well as the freedom to shift study resources from time-consuming TMF management to other critical objectives, reducing the risk of inspection findings and submission delays.
“You can think of PhlexTMF+ as ‘TMF management as a service,’” observes Karen Roy, Phlexglobal’s Chief Strategy Officer and Chair, TMF Reference Model. “By delivering everything critical to Trial Master File health, including purpose-built SaaS eTMF software, workflows, and expert guidance, we remove the burden of TMF compliance from our customers.”
Building on Phlexglobal’s decades of industry leadership in Trial Master File technology and best practices, the innovative new solution standardizes end-to-end TMF management to ensure consistent, accurate, and current compliance throughout the TMF lifecycle. What’s more, PhlexTMF+ fits each organization’s unique requirements, providing agile, fit-for-purpose TMF management – eliminating paying for software and services that don’t support TMF health.
Key benefits of PhlexTMF+ include:
“PhlexTMF+ is further evidence of Phlexglobal’s authoritative position helping life sciences companies worldwide stay compliant with ever-shifting regulatory mandates,” said John McNeill, Chief Executive Officer of Phlexglobal. “We’ve transformed a traditionally siloed and challenging TMF management process into a seamless, expert solution from a single source, providing our customers with even greater compliance peace of mind.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.